Controlling Drug Partitioning in Individual Protein Condensates through Laser-Induced Microscale Phase Transitions

Axel Leppert*, Jianhui Feng, Vaida Railaite, Tomas Bohn Pessatti, Carmine P. Cerrato, Cecilia Mörman, Hannah Osterholz, David P. Lane, Filipe R.N.C. Maia, Markus B. Linder, Anna Rising*, Michael Landreh*

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

12 Citations (Scopus)
39 Downloads (Pure)

Abstract

Gelation of protein condensates formed by liquid-liquid phase separation occurs in a wide range of biological contexts, from the assembly of biomaterials to the formation of fibrillar aggregates, and is therefore of interest for biomedical applications. Soluble-to-gel (sol-gel) transitions are controlled through macroscopic processes such as changes in temperature or buffer composition, resulting in bulk conversion of liquid droplets into microgels within minutes to hours. Using microscopy and mass spectrometry, we show that condensates of an engineered mini-spidroin (NT2repCTYF) undergo a spontaneous sol-gel transition resulting in the loss of exchange of proteins between the soluble and the condensed phase. This feature enables us to specifically trap a silk-domain-tagged target protein in the spidroin microgels. Surprisingly, laser pulses trigger near-instant gelation. By loading the condensates with fluorescent dyes or drugs, we can control the wavelength at which gelation is triggered. Fluorescence microscopy reveals that laser-induced gelation significantly further increases the partitioning of the fluorescent molecules into the condensates. In summary, our findings demonstrate direct control of phase transitions in individual condensates, opening new avenues for functional and structural characterization.

Original languageEnglish
Pages (from-to)19555-19565
JournalJournal of the American Chemical Society
Volume146
Issue number28
Early online date4 Jul 2024
DOIs
Publication statusPublished - 17 Jul 2024
MoE publication typeA1 Journal article-refereed

Funding

M.L. is supported by a KI faculty-funded Career Position, a Cancerfonden project grant (22-2023 Pj), a VR starting grant (2019-01961), and a Consolidator grant from the Swedish Society for Medical Research (SSMF). A.L. is supported by the Olle Engkvist Foundation (to M.L.). C.M. is supported by a V.R. postdoc grant (2021-00418) and the Gun and Bertil Stohnes Foundation. A.R. is supported by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement no. 815357), Olle Engkvist Foundation (207-0375), the Center for Innovative Medicine (CIMED) at Karolinska Institutet and Stockholm City Council, the Swedish Research Council (2019-01257), and Formas (2019-00427). DPL is supported by a Swedish Research Council grant for Internationally Recruited Scientists (2013-08807). J.F. and M.B.L. were supported by the Academy of Finland (346105) and the Novo Nordisk Foundation (NNF20OC0061306).

Fingerprint

Dive into the research topics of 'Controlling Drug Partitioning in Individual Protein Condensates through Laser-Induced Microscale Phase Transitions'. Together they form a unique fingerprint.
  • LIBER Linder: Life-like hybrid materials

    Linder, M. (Principal investigator), Lemetti, L. (Project Member), Elfving, K. (Project Member), Malkamäki, M. (Project Member), Fedorov, D. (Project Member), Roas Escalona, N. (Project Member), Khanum, S. (Project Member), Ateş, C. (Project Member), Hannikainen, B. (Project Member), Aspelin, H. (Project Member), Tunn, I. (Project Member), Osmekhina, E. (Project Member) & Aranko, S. (Project Member)

    01/01/202231/12/2026

    Project: RCF Centre of Excellence

Cite this